Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction Read more about Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma Read more about Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
Vitamin D to Improve Outcomes by Leveraging Early Treatment Read more about Vitamin D to Improve Outcomes by Leveraging Early Treatment
Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial Read more about Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children Read more about An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
Observational Study of Obstructive Lung Disease (NOVELTY) Read more about Observational Study of Obstructive Lung Disease (NOVELTY)
Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia Read more about Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia
Effect of Angulus on Patient-elevation Compliance Read more about Effect of Angulus on Patient-elevation Compliance
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) Read more about A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff Read more about Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff